Back to top

United Therapeutics (UTHR) Gets a Buy from Wells Fargo

Wells Fargo analyst Benjamin Burnett maintained a Buy rating on United Therapeutics yesterday and set a price target of $738.00. The company’s shar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

United Therapeutics Corporation (UTHR)